We found that 19 of the 23 OSCC patients (82.6 %, p < 0.05) showed remarkably higher expression of FOXC1 mRNA in tumor tissues than in noncancerous tissues (Fig. 1a). This evidence concerns the gene FOXC1 and neoplasm.